Work

ent -Kaurene, ent -kauran-16-ol, and shunted diterpenoids from an engineered strain of Aspergillus oryzae

Year: 2026
Type: article
Abstract: Aspergillus oryzae was engineered to produce high levels of geranylgeranyldiphosphate (GGPP) and ent -kaurene, via ent -copalyl diphosphate, as precursors for future metabolic engineering projects via the expression of ggs2 and cps/ks genes from Gibberella fujikuroi under the control of strong constitutive promoters. GGPP was shunted to three new metabolites that were fully identified by NMR and HRMS. ent -Copalyl diphosphate was shunted to a further seven new compounds that were also identified by NMR and HRMS. The titre of ent -kaurene was significantly increased by heterologous expression of a truncated hydroxymethylglutaryl CoA reductase gene from Avena strigosa (AstHMGR), while replacement of the dual terpene cyclase encoding gene cps/ks with the individual cyclase genes ptmT2 from Streptomyces platensis and Bjks from Bradyrhizobium japonicum resulted mainly in accumulation of ent -copalyl diphosphate-derived shunt products. Finally, ent -kauran-16-ol was biosynthesised by coexpression of ggs2 with the bacterial cyclases ptmT2 and ptmT3 .
Source: RSC Advances
Language: English
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7204270668
FWCI:
Cites: 29
Cited by:
Related to: 10